Investment Summary |
|
|---|---|
| Date | 2007-05-07 |
| Target | Aeon Bioscience |
| Sector | Life Science |
| Investor(s) | Greer Capital Advisors |
| Deal Type | Venture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2002 |
| Size | Small |
| Type | Sector Focused |
Greer Capital Advisors (GCA) is a specialized, heathcare focused private equity firm that targets investments in Alabama based companies. Within healthcare, GCA looks for companies in the pharmaceutical, biotechnology, medical device, and diagnostics industries. GCA prefers early and growth stage investments and generally seeks to invest between $1 to $2 million per transaction. Greer Capital Advisors was formed in 2002 and is based in Birmingham, Alabama.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 8 |
| Sector: Life Science M&A | 3 of 6 |
| Type: Venture M&A Deals | 4 of 7 |
| State: Alabama M&A | 2 of 5 |
| Country: United States M&A | 5 of 8 |
| Year: 2007 M&A | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-10-31 |
Genaco Biomedical Products
Valencia, California, United States Genaco Biomedical Products, Inc. (Genaco) is a post-genomic era biotechnology platform company, utilizing the information and technologies derived from the Human Genome Project (HGP) to develop molecular differential diagnostics (MDD). |
Sell | $40M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-07-06 |
PNP Therapeutics
Birmingham, Alabama, United States PNP Therapeutics is an operator of clinical-stage, a biopharmaceutical company engaged in the development of a platform technology and proprietary products for the treatment of cancer. PNP Therapeutics is based in Birmingham, Alabama. |
Buy | - |
